SB-485232

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SB-485232, covering 2008-10-13 to 2017-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma [Phase 2]